{
    "title": "FDA panel says Vertex/CRISPR to assess safety risks of gene therapy in follow-up study",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12695379/FDA-panel-says-Vertex-CRISPR-assess-safety-risks-gene-therapy-follow-study.html",
    "date": "2023-10-31",
    "keywords": [
        "therapy",
        "panel",
        "health",
        "vertex",
        "safety",
        "cell",
        "gene",
        "approval",
        "crisis",
        "blood",
        "technology",
        "drug",
        "target",
        "exacel",
        "regulator",
        "crispr",
        "sickle",
        "disease",
        "redbloodcell",
        "disorder",
        "hemoglobin",
        "body",
        "flow",
        "point",
        "oxygen",
        "monitoring",
        "staff",
        "food",
        "administration",
        "type",
        "side",
        "therapys",
        "exagamglogene",
        "autotemcel",
        "goal",
        "latestage",
        "study",
        "infusion",
        "analysis",
        "enemy",
        "scot",
        "wolfe",
        "professor",
        "department",
        "cancer",
        "biology",
        "umass",
        "chan",
        "school",
        "product",
        "fda",
        "review",
        "dec",
        "offtarget",
        "analyst",
        "roy",
        "bengaluru",
        "editing",
        "krishna",
        "chandra",
        "eluri"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}